Chế độ ăn tăng cường miễn dịch: Câu trả lời cuối cùng là gì?

Wei X et al. The association between nutritional adequacy and long-term outcomes in critically Ill patients requiring prolonged mechanical ventilation: a multicenter cohort study. Crit Care Med. 2015;43(8):1569–79. Heyland DK. Should we PERMIT systematic underfeeding in all intensive care unit patients? Integrating the results of the PERMIT study in Our clinical practice guidelines. JPEN J Parenter Enteral Nutr. 2016;40(2):156–8. Wade CE et al. Evaluation of nutrition deficits in adult and elderly trauma patients. JPEN J Parenter Enteral Nutr. 2015;39(4):449–55. Chapple LA et al. Nutrition support practices in critically ill head-injured patients: a global perspective. Crit Care. 2016;20(1):6. Wilson RF, Tyburski JG. Metabolic responses and nutritional therapy in patients with severe head injuries. J Head Trauma Rehabil. 1998;13(1):11–27. Brandi LS et al. Energy expenditure and severity of injury and illness indices in multiple trauma patients. Crit Care Med. 1999;27(12):2684–9. Marik PE, Flemmer M. The immune response to surgery and trauma: implications for treatment. J Trauma Acute Care Surg. 2012;73(4):801–8. Askanazi J et al. Muscle and plasma amino acids after injury: hypocaloric glucose vs. amino acid infusion. Ann Surg. 1980;191(4):465–72. Alexander JW. Nutritional pharmacology in surgical patients. Am J Surg. 2002;183(4):349–52. Jones NE, Heyland DK. Pharmaconutrition: a new emerging paradigm. Curr Opin Gastroenterol. 2008;24(2):215–22. Bongers T, Griffiths RD, McArdle A. Exogenous glutamine: the clinical evidence. Crit Care Med. 2007;35(9 Suppl):S545–52. Gore DC, Jahoor F. Glutamine kinetics in burn patients. Comparison with hormonally induced stress in volunteers. Arch Surg. 1994;129(12):1318–23. Jackson NC et al. The metabolic consequences of critical illness: acute effects on glutamine and protein metabolism. Am J Physiol. 1999;276(1 Pt 1):E163–70. Rodas PC et al. Glutamine and glutathione at ICU admission in relation to outcome. Clin Sci (Lond). 2012;122(12):591–7. Oudemans-van Straaten HM et al. Plasma glutamine depletion and patient outcome in acute ICU admissions. Intensive Care Med. 2001;27(1):84–90. Rosenthal MD et al. Evolving paradigms in the nutritional support of critically ill surgical patients. Curr Probl Surg. 2015;52(4):147–82. Wernerman J. Role of glutamine supplementation in critically ill patients. Curr Opin Anaesthesiol. 2008;21(2):155–9. Flynn Jr WJ, Gosche JR, Garrison RN. Intestinal blood flow is restored with glutamine or glucose suffusion after hemorrhage. J Surg Res. 1992;52(5):499–504. Furukawa S et al. Glutamine-enriched enteral diet enhances bacterial clearance in protected bacterial peritonitis, regardless of glutamine form. JPEN J Parenter Enteral Nutr. 1997;21(4):208–14. Saito H, Furukawa S, Matsuda T. Glutamine as an immunoenhancing nutrient. JPEN J Parenter Enteral Nutr. 1999;23(5 Suppl):S59–61. Novak F et al. Glutamine supplementation in serious illness: a systematic review of the evidence. Crit Care Med. 2002;30(9):2022–9. Heyland D et al. A randomized trial of glutamine and antioxidants in critically ill patients. N Engl J Med. 2013;368(16):1489–97. The REDOX trial was the largest and most rigorous trial of glutamine in critically ill patients. This landmark trial demonstrated no benefit of glutamine and antioxidant supplementation and showed a trend towards increased mortality. Heyland DK et al. Glutamine and antioxidants in the critically ill patient: a post hoc analysis of a large-scale randomized trial. JPEN J Parenter Enteral Nutr. 2015;39(4):401–9. van Zanten AR et al. High-protein enteral nutrition enriched with immune-modulating nutrients vs standard high-protein enteral nutrition and nosocomial infections in the ICU: a randomized clinical trial. JAMA. 2014;312(5):514–24. Van den Berghe G. Low glutamine levels during critical illness—adaptive or maladaptive? N Engl J Med. 2013;368(16):1549–50. Bickell WH et al. Immediate versus delayed fluid resuscitation for hypotensive patients with penetrating torso injuries. N Engl J Med. 1994;331(17):1105–9. Schreiber, M.A., et al., A controlled resuscitation strategy is feasible and safe in hypotensive trauma patients: results of a prospective randomized pilot trial. J Trauma Acute Care Surg, 2015. 78(4): p. 687–95; discussion 695–7. van Zanten AR, Hofman Z, Heyland DK. Consequences of the REDOXS and METAPLUS trials: the end of an era of glutamine and antioxidant supplementation for critically Ill patients? JPEN J Parenter Enteral Nutr. 2015;39(8):890–2. Heyland DK, Dhaliwal R. Role of glutamine supplementation in critical illness given the results of the REDOXS study. JPEN J Parenter Enteral Nutr. 2013;37(4):442–3. Kempski O et al. Intravenous glutamate enhances edema formation after a freezing lesion. Adv Neurol. 1990;52:219–23. Yi JH, Hazell AS. Excitotoxic mechanisms and the role of astrocytic glutamate transporters in traumatic brain injury. Neurochem Int. 2006;48(5):394–403. Nageli M et al. Prolonged continuous intravenous infusion of the dipeptide L-alanine- L-glutamine significantly increases plasma glutamine and alanine without elevating brain glutamate in patients with severe traumatic brain injury. Crit Care. 2014;18(4):R139. Berg A et al. Intravenous glutamine supplementation to head trauma patients leaves cerebral glutamate concentration unaffected. Intensive Care Med. 2006;32(11):1741–6. van Zanten AR et al. Enteral glutamine supplementation in critically ill patients: a systematic review and meta-analysis. Crit Care. 2015;19:294. Taylor BE et al. Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.). Crit Care Med. 2016;44(2):390–438. This recently published set of guidelines represents a synthesis of the best available evidence in critically ill adults. Grintescu IM et al. The influence of parenteral glutamine supplementation on glucose homeostasis in critically ill polytrauma patients—a randomized-controlled clinical study. Clin Nutr. 2015;34(3):377–82. de Arruda Falcao IS, de Aguilar-Nascimento JE. Benefits of early enteral nutrition with glutamine and probiotics in brain injury patients. Clin Sci (Lond). 2004;106(3):287–92. Eroglu A. The effect of intravenous alanyl-glutamine supplementation on plasma glutathione levels in intensive care unit trauma patients receiving enteral nutrition: the results of a randomized controlled trial. Anesth Analg. 2009;109(2):502–5. Houdijk AP et al. Randomised trial of glutamine-enriched enteral nutrition on infectious morbidity in patients with multiple trauma. Lancet. 1998;352(9130):772–6. Perez-Barcena J et al. A randomized trial of intravenous glutamine supplementation in trauma ICU patients. Intensive Care Med. 2014;40(4):539–47. Wischmeyer PE et al. Glutamine administration reduces Gram-negative bacteremia in severely burned patients: a prospective, randomized, double-blind trial versus isonitrogenous control. Crit Care Med. 2001;29(11):2075–80. Jensen GL et al. A double-blind, prospective, randomized study of glutamine-enriched compared with standard peptide-based feeding in critically ill patients. Am J Clin Nutr. 1996;64(4):615–21. Mendez, C., et al., Effects of an immune-enhancing diet in critically injured patients. J Trauma, 1997. 42(5): p. 933–40; discussion 940–1. Lorenz, K.J., R. Schallert, and V. Daniel, Immunonutrition—the influence of early postoperative glutamine supplementation in enteral/parenteral nutrition on immune response, wound healing and length of hospital stay in multiple trauma patients and patients after extensive surgery. GMS Interdiscip Plast Reconstr Surg DGPW, 2015. 4: p. Doc15. Zaloga GP et al. Arginine: mediator or modulator of sepsis? Nutr Clin Pract. 2004;19(3):201–15. Yeh CL et al. Effects of arginine-containing total parenteral nutrition on N balance and phagocytic activity in rats undergoing a partial gastrectomy. Br J Nutr. 2005;93(2):267–72. Muhling J et al. Alterations in neutrophil (PMN) free intracellular alpha-keto acid profiles and immune functions induced by L-alanyl-L-glutamine, arginine or taurine. Amino Acids. 2005;29(3):289–300. Chiarla C, Giovannini I, Siegel JH. Plasma arginine correlations in trauma and sepsis. Amino Acids. 2006;30(1):81–6. Yu YM et al. Plasma arginine and leucine kinetics and urea production rates in burn patients. Metabolism. 1995;44(5):659–66. Yu YM et al. Arginine and ornithine kinetics in severely burned patients: increased rate of arginine disposal. Am J Physiol Endocrinol Metab. 2001;280(3):E509–17. Jeevanandam M et al. Effect of major trauma on plasma free amino acid concentrations in geriatric patients. Am J Clin Nutr. 1990;51(6):1040–5. Zhou M, Martindale RG. Arginine in the critical care setting. J Nutr. 2007;137(6 Suppl 2):1687S–92S. Davis JS, Anstey NM. Is plasma arginine concentration decreased in patients with sepsis? A systematic review and meta-analysis. Crit Care Med. 2011;39(2):380–5. Bruins MJ et al. L-arginine supplementation in hyperdynamic endotoxemic pigs: effect on nitric oxide synthesis by the different organs. Crit Care Med. 2002;30(3):508–17. Lorente JA et al. Modulation of systemic hemodynamics by exogenous L-arginine in normal and bacteremic sheep. Crit Care Med. 1999;27(11):2474–9. Bertolini G et al. Early enteral immunonutrition in patients with severe sepsis: results of an interim analysis of a randomized multicentre clinical trial. Intensive Care Med. 2003;29(5):834–40. Bower RH et al. Early enteral administration of a formula (Impact) supplemented with arginine, nucleotides, and fish oil in intensive care unit patients: results of a multicenter, prospective, randomized, clinical trial. Crit Care Med. 1995;23(3):436–49. Heyland DK, Samis A. Does immunonutrition in patients with sepsis do more harm than good? Intensive Care Med. 2003;29(5):669–71. Chiu LS et al. The neuroprotective potential of arginine-rich peptides for the acute treatment of traumatic brain injury. Expert Rev Neurother. 2016;16(4):361–3. Popovic PJ, Zeh 3rd HJ, Ochoa JB. Arginine and immunity. J Nutr. 2007;137(6 Suppl 2):1681S–6S. Yan H et al. Effects of early enteral arginine supplementation on resuscitation of severe burn patients. Burns. 2007;33(2):179–84. http://criticalcarenutrition.com/docs/CPGs%202015/4.1a%202015.pdf (Accessed April 30, 2016). Gadek JE et al. Effect of enteral feeding with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants in patients with acute respiratory distress syndrome. Enteral Nutrition in ARDS Study Group. Crit Care Med. 1999;27(8):1409–20. Pontes-Arruda A, Aragao AM, Albuquerque JD. Effects of enteral feeding with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants in mechanically ventilated patients with severe sepsis and septic shock. Crit Care Med. 2006;34(9):2325–33. Singer P et al. Benefit of an enteral diet enriched with eicosapentaenoic acid and gamma-linolenic acid in ventilated patients with acute lung injury. Crit Care Med. 2006;34(4):1033–8. Grau-Carmona T et al. Effect of an enteral diet enriched with eicosapentaenoic acid, gamma-linolenic acid and anti-oxidants on the outcome of mechanically ventilated, critically ill, septic patients. Clin Nutr. 2011;30(5):578–84. Rice TW et al. Enteral omega-3 fatty acid, gamma-linolenic acid, and antioxidant supplementation in acute lung injury. JAMA. 2011;306(14):1574–81. The OMEGA trial was the largest and most rigorous trial of fish-oils in adults with acute respiratory distress syndrome (ARDS). It was terminated early for futility. Hasadsri L et al. Omega-3 fatty acids as a putative treatment for traumatic brain injury. J Neurotrauma. 2013;30(11):897–906. Barrett EC, McBurney MI, Ciappio ED. Omega-3 fatty acid supplementation as a potential therapeutic aid for the recovery from mild traumatic brain injury/concussion. Adv Nutr. 2014;5(3):268–77. Mills JD et al. Omega-3 fatty acid supplementation and reduction of traumatic axonal injury in a rodent head injury model. J Neurosurg. 2011;114(1):77–84. Michael-Titus AT, Priestley JV. Omega-3 fatty acids and traumatic neurological injury: from neuroprotection to neuroplasticity? Trends Neurosci. 2014;37(1):30–8. Bailes JE, Mills JD. Docosahexaenoic acid reduces traumatic axonal injury in a rodent head injury model. J Neurotrauma. 2010;27(9):1617–24. Begum G et al. Docosahexaenoic acid reduces ER stress and abnormal protein accumulation and improves neuronal function following traumatic brain injury. J Neurosci. 2014;34(10):3743–55. Wu A, Ying Z, Gomez-Pinilla F. The salutary effects of DHA dietary supplementation on cognition, neuroplasticity, and membrane homeostasis after brain trauma. J Neurotrauma. 2011;28(10):2113–22. King VR et al. Omega-3 fatty acids improve recovery, whereas omega-6 fatty acids worsen outcome, after spinal cord injury in the adult rat. J Neurosci. 2006;26(17):4672–80. Huang WL et al. A combination of intravenous and dietary docosahexaenoic acid significantly improves outcome after spinal cord injury. Brain. 2007;130(Pt 11):3004–19. Lewis M, Ghassemi P, Hibbeln J. Therapeutic use of omega-3 fatty acids in severe head trauma. Am J Emerg Med. 2013;31(1):273 e5-8. Roberts L et al. Surviving a mine explosion. J Am Coll Surg. 2008;207(2):276–83. Kagan I et al. Preemptive enteral nutrition enriched with eicosapentaenoic acid, gamma-linolenic acid and antioxidants in severe multiple trauma: a prospective, randomized, double-blind study. Intensive Care Med. 2015;41(3):460–9. Heyland DK et al. Should immunonutrition become routine in critically ill patients? A systematic review of the evidence. JAMA. 2001;286(8):944–53. Beale RJ, Bryg DJ, Bihari DJ. Immunonutrition in the critically ill: a systematic review of clinical outcome. Crit Care Med. 1999;27(12):2799–805. Bollhalder L et al. A systematic literature review and meta-analysis of randomized clinical trials of parenteral glutamine supplementation. Clin Nutr. 2013;32(2):213–23. Marik PE, Zaloga GP. Immunonutrition in critically ill patients: a systematic review and analysis of the literature. Intensive Care Med. 2008;34(11):1980–90. Marik PE, Zaloga GP. Immunonutrition in high-risk surgical patients: a systematic review and analysis of the literature. JPEN J Parenter Enteral Nutr. 2010;34(4):378–86. Montejo JC et al. Immunonutrition in the intensive care unit. A systematic review and consensus statement. Clin Nutr. 2003;22(3):221–33. Palmer AJ et al. The role of omega-3 fatty acid supplemented parenteral nutrition in critical illness in adults: a systematic review and meta-analysis. Crit Care Med. 2013;41(1):307–16. Singer M et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):801–10. Beale RJ et al. Early enteral supplementation with key pharmaconutrients improves sequential organ failure assessment score in critically ill patients with sepsis: outcome of a randomized, controlled, double-blind trial. Crit Care Med. 2008;36(1):131–44. Kudsk, K.A., et al., A randomized trial of isonitrogenous enteral diets after severe trauma. An immune-enhancing diet reduces septic complications. Ann Surg, 1996. 224(4): p. 531–40; discussion 540–3. Loi C et al. Increasing plasma glutamine in postoperative patients fed an arginine-rich immune-enhancing diet—a pharmacokinetic randomized controlled study. Crit Care Med. 2009;37(2):501–9. Wiedemann HP. Fish oil is not the fix for acute lung injury. Crit Care Med. 2011;39(7):1829–30. Kaukonen KM et al. Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000–2012. JAMA. 2014;311(13):1308–16. Fadda V et al. Temporal trend of short-term mortality in severely ill patients receiving parenteral glutamine supplementation. Clin Nutr. 2013;32(3):492–3. Wischmeyer P. Glutamine supplementation in parenteral nutrition and intensive care unit patients: are we throwing the baby Out with the bathwater? JPEN J Parenter Enteral Nutr. 2015;39(8):893–7. Krenitsky, J., Immunonutrition—fact, fancy or folly? Practical Gastroenterology, 2006. May.